TrialThe New England journal of medicine2021
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.
Sven M Francque et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
393 papers cite itlatest 60 shown
this paperpooled ittrialcites it